Geoffrey Lawrence is the managing director of drug policy at Reason Foundation.
Lawrence is also currently the chief financial officer of Claybourne, Co., a licensed cannabis company.
Lawrence has broad experience as a financial executive in the public and private sectors and a decade as a think tank analyst. Lawrence was previously Chief Financial Officer and Chief Compliance Officer at Players Network, Inc, the first fully reporting, publicly-traded marijuana company to be listed on a U.S. exchange. Lawrence oversaw all aspects of compliance with state and local laws and regulations for the licensed cultivation operations across two states.
Prior to that, Lawrence served as the senior appointee to the Nevada State Controller’s Office., where he oversaw external financial reporting, covering nearly $10 billion in annual transactions, on behalf of the state. During each year of Lawrence’s tenure, the state received the Certificate of Achievement for Excellence in Financial Reporting Award from the Government Finance Officers’ Association.
Lawrence spent a decade developing market-based solutions to challenges facing state governments while working at the Nevada Policy Research Institute and, previously, the John Locke Foundation in North Carolina. Lawrence has also written for the Cato Institute and the Heritage Foundation, with particular expertise in state budgets and labor economics.
Lawrence holds an M.A. in international economics from American University in Washington, D.C., an M.S. and a B.S. in accounting from Western Governors University, and a B.A. in international relations from the University of North Carolina at Pembroke.
-
How to reform the FDA
Reimagining pharmaceutical regulation, so it better serves society’s needs by encouraging widespread availability of life-saving drugs at lower prices.
-
The impact of California’s cannabis taxes on participation within the legal market
This analysis develops an empirical model to estimate the degree to which California’s tax regime affects participation within its commercial cannabis market, and how participation may change through different approaches to taxation.
-
Frequently asked questions about the States Reform Act, a proposed marijuana bill
Rep. Nancy Mace (R-SC) unveiled the States Reform Act, a proposal to remove marijuana from the auspices of the federal Controlled Substances Act.
-
COVID-19 Lockdown Problems and Alternative Strategies to Safely Reopening the Economy
Part one of a series discussing strategies for combating and recovering from the coronavirus pandemic. More data-driven approaches based on test and trace are desirable.
-
Marijuana Taxation and Black Market Crowd-Out
Tax rates that elevate the price of legal marijuana significantly above black market prices prolong the presence of illegal markets and reduce government tax receipts.
-
Marijuana Industry Financial Services: The Obstacles and the Policy Solutions
Denying marijuana-related businesses the legitimate financial services available to other businesses prevents oversight, facilitates illegal sales, and may allow these businesses to conceal tax liabilities.
-
A Historical Review of State Efforts and Authority To Regulate Cannabis
The history of cannabis regulation begins largely in California during the Gold Rush.
-
A Conceptual Framework for State Efforts to Legalize and Regulate Cannabis
Best practices that policymakers should use for improving their existing marijuana markets or establishing new ones.